First New York Securities’s Gilead Sciences GILD Stock Holding History

First New York Securities’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-24,500	Closed	-$1.74M	–	258
2014 Q1	$1.74M	Buy	+24,500	New	+$1.92M	0.85%	23

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First New York Securities's GILD Position: Q2 2014 in Review

First New York Securities sold out of Gilead Sciences (GILD) in Q2 2014, closing a stake of 24,500 shares — an estimated $1.74M sold.

First New York Securities first reported a position in GILD in Q1 2014 and held it in 1 quarter. The position peaked at $1.74M in Q1 2014. 1,264 funds tracked by Wall St. Rank hold GILD as of Q2 2014.

First New York Securities reported no remaining Gilead Sciences position as of Q2 2014 after selling out during the quarter.
First New York Securities sold 24,500 Gilead Sciences shares in Q2 2014, an estimated $1.74M.
First New York Securities first reported a position in Gilead Sciences in Q1 2014 and held it in 1 quarter.
First New York Securities's Gilead Sciences position peaked at $1.74M in Q1 2014.
1,264 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2014.

Based on First New York Securities's 13F filing for Q2 2014, filed 15 Aug 2014.